U.S. Construction Stock News

NasdaqGS:DFTX
NasdaqGS:DFTXPharmaceuticals

What Do Definium Therapeutics (DFTX) Phase 3 GAD Results Mean For DT120?

Definium Therapeutics (NasdaqGS: DFTX) reported positive topline Phase 3 Voyage study results for DT120 ODT in adults with generalized anxiety disorder. The trial met its primary and secondary efficacy endpoints versus placebo, with a statistically significant and clinically meaningful benefit. The data may support upcoming regulatory filings for DT120 ODT in generalized anxiety disorder, addressing a large unmet treatment need. This kind of progress in generalized anxiety disorder...
NYSE:ENS
NYSE:ENSElectrical

EnerSys (ENS) Lifts Dividend And Guidance On A Narrative That Still Looks Undervalued

EnerSys (ENS) has given investors several fresh data points to consider after announcing a 10% increase in its quarterly dividend, along with new sales guidance and detailed recent earnings and buyback activity. See our latest analysis for EnerSys. Against this backdrop of higher dividends, guidance and buybacks, EnerSys shares trade at $186.72 after a year to date share price return of 23.88%, while the 1 year total shareholder return of 87.26% points to strong longer term momentum. If...
NYSE:FAF
NYSE:FAFInsurance

Does FAF’s Above-Peer Dividend Yield Reveal a Distinct Capital Allocation Strategy for Investors?

Recently, First American Financial Corporation highlighted its role as an income-focused stock, with a dividend yield above the Insurance – Property and Casualty industry average, supported by a relatively low payout ratio and a history of multiple dividend increases over the past five years. An interesting implication is that this combination of higher-than-peer yield and modest payout levels may give the company room to continue prioritizing shareholder income if its earnings grow as...
NYSE:LYV
NYSE:LYVEntertainment

Live Nation Entertainment (LYV) Could Be 8% Undervalued As Q2 Earnings Lift The Stock

Live Nation Entertainment (LYV) is back in focus after reporting second quarter 2026 results, with higher sales and net income than a year earlier. This has prompted fresh attention on the stock’s recent move. See our latest analysis for Live Nation Entertainment. At a share price of $185.33, Live Nation Entertainment has gained momentum recently, with a 27.54% year to date share price return and a 116.51% three year total shareholder return hinting at investors reassessing its prospects...
NYSE:CIEN
NYSE:CIENCommunications

Ciena (CIEN) Stock Looks Undervalued Following Its Near 10x Three Year Run

Ciena stock has delivered an extremely strong three year return while the valuation checks send mixed signals, with an intrinsic value estimate from a Discounted Cash Flow (DCF) model suggesting the shares trade below that estimate and market multiples pointing to a richer price. Ciena has returned very close to 10x over the past three years, which puts recent gains firmly in focus for anyone considering the potential for additional upside from here. Investor expectations around AI driven...
NasdaqGM:FCEL
NasdaqGM:FCELElectrical

Does Power‑Generating Carbon Capture Tech Shift the Bull Case for FuelCell Energy (FCEL)?

FuelCell Energy recently highlighted its carbonate fuel cell–based carbon capture platform, which integrates directly into coal and natural gas plant exhaust streams to cut emissions while generating additional electricity. This approach stands out because, unlike many carbon capture systems that consume power, FuelCell Energy’s technology can add an extra electricity revenue stream and be scaled from small installations to full fuel cell parks. We’ll now examine how this power-generating...
NYSE:AGO
NYSE:AGOInsurance

Do Weaker Alternative Returns Change the Risk‑Reward Balance in Assured Guaranty’s (AGO) Capital Strategy?

In the past quarter, Assured Guaranty Ltd. reported weaker Q2 2026 results, with revenue falling to US$195 million and net income to US$39 million, while also continuing share repurchases, completing a long-running buyback, and affirming a quarterly dividend of US$0.38 per share. Management linked the earnings shortfall mainly to reduced alternative investment returns, including a mark-to-market loss on a CLO equity fund and credit-related liquidity pressures, even as the group continued to...
NYSE:HIG
NYSE:HIGInsurance

Does Hartford Insurance Group (HIG) Have More To Gain From This Board Pick?

Hartford Insurance Group (NYSE:HIG) appointed Priscilla Almodovar, former president and CEO of Fannie Mae, to its Board of Directors. Almodovar brings leadership experience from major financial institutions, including Fannie Mae and JPMorgan Chase. The appointment adds additional depth in areas such as risk management, finance, and investment oversight for Hartford Insurance Group. For readers looking to explore more companies with an emphasis on resilience and disciplined risk management,...
NYSE:CNP
NYSE:CNPIntegrated Utilities

CenterPoint Energy (CNP) Is Getting Attention Today, What Is Behind It?

CenterPoint Energy (CNP) recently announced a Customer Savings Initiative that targets more than $5 billion in savings for Texas electric customers over the next decade, focusing on lower infrastructure charges and regulatory alignment. See our latest analysis for CenterPoint Energy. CenterPoint Energy’s Customer Savings Initiative lands at a time when the stock’s 1-day share price return of 0.87% contrasts with a 30-day share price decline of 8.16%, while the 5-year total shareholder return...
NasdaqGS:UTHR
NasdaqGS:UTHRBiotechs

United Therapeutics (UTHR) Stock Looks Undervalued Despite Fresh NDA Filings

United Therapeutics stock has delivered strong gains over the past five years, yet current valuation checks still suggest the shares screen as inexpensive relative to the company’s fundamentals. After recent Q2 news around new drug applications and organ manufacturing plans, investors are weighing whether the market is already pricing in too much of that future potential or still leaving a margin of safety. United Therapeutics has returned 151.6% over the past five years, which puts the...
NYSE:TUYA
NYSE:TUYASoftware

How Investors May Respond To Tuya (TUYA) Opening AI App Creation To Non‑Coders With Tuya AI Coding

Tuya Smart recently launched Tuya AI Coding, a no-code, AI-native development platform that lets users create deployable AI-powered lifestyle applications from natural-language prompts, with built-in device connectivity, cloud services, and data intelligence. By tying AI-generated applications directly into an ecosystem of more than 100,000 supported IoT device SKUs, Tuya is aiming to turn non-technical users such as designers and entrepreneurs into contributors to its AIoT ecosystem. Next,...
NYSE:LOAR
NYSE:LOARAerospace & Defense

Loar Holdings (LOAR) Reported Stronger Sales, Is It Still Below Fair Value?

Loar Holdings (LOAR) drew investor focus after reporting second quarter 2026 earnings that showed higher sales, flat quarterly profit, and lower net income for the first half of the year compared with 2025. See our latest analysis for Loar Holdings. Loar Holdings shares closed at $73.53, with a 90 day share price return of 18.46% that offsets a softer 7 day share price return of 2.82% and a 1 year total shareholder return of 7.77%. This suggests momentum has cooled slightly after earlier...
NasdaqGS:AVGO
NasdaqGS:AVGOSemiconductor

Is Broadcom (AVGO) Stock Above Fair Value After Its 15% Drop?

Broadcom has delivered a very large 5 year return of about 8.7x, yet its current checks send a more cautious signal, as the intrinsic value estimate from a Discounted Cash Flow (DCF) model sits close to the market price while traditional earnings multiples lean expensive. Broadcom’s share price has returned roughly 874% over 5 years, which raises the question of how much of the AI and data center growth story is already reflected in today’s valuation. Growing demand for custom AI chips and...
NYSE:MSGS
NYSE:MSGSEntertainment

Madison Square Garden Sports (MSGS) Rides Lakers Sale Buzz, Is The Stock Fully Priced?

Why Madison Square Garden Sports is Back in Focus The record US$12b sale agreement for the Los Angeles Lakers and talk of possible NBA expansion have pushed Madison Square Garden Sports (MSGS) into the spotlight for investors watching franchise valuation trends. See our latest analysis for Madison Square Garden Sports. Alongside the Lakers sale, Madison Square Garden Sports has picked up strong momentum, with a 59.98% year to date share price return and a 112.89% total shareholder return over...
NasdaqGS:CGON
NasdaqGS:CGONBiotechs

CG Oncology (CGON) Faces A Fair Value Gap Following Its Latest Earnings

What CG Oncology’s Latest Earnings Tell You About the Business CG Oncology (CGON) recently posted second quarter and first half 2026 results, giving investors fresh detail on how revenue and losses are tracking for this late stage bladder cancer focused biotech. For the quarter ended June 30, 2026, CG Oncology reported revenue of US$1.16 million. The company recorded a net loss of US$79.06 million and a basic loss per share from continuing operations of US$0.90. For the first six months of...
NasdaqGM:PAHC
NasdaqGM:PAHCPharmaceuticals

Phibro Animal Health (PAHC) Stock Looks Undervalued On Earnings Yet Mixed Elsewhere

Phibro Animal Health has delivered a strong 139.6% return over the past three years, yet its current valuation checks offer a more restrained read on how cheap the stock really is today. Phibro Animal Health's share price is up 139.6% over three years, which puts extra focus on whether the current level is already baking in much of the improvement investors were looking for. Future expectations for the company’s animal health portfolio can support the current price, while any pressure on...
NasdaqGS:MYRG
NasdaqGS:MYRGConstruction

Does MYR Group’s Acquisition Push, Funded by MYRG’s Balance Sheet, Deepen the Long-Term Infrastructure Story?

In its second-quarter 2026 earnings call, MYR Group highlighted strong results and reiterated that existing credit capacity and operating cash flow should support organic expansion, potential acquisitions, and opportunistic share repurchases. This focus on acquisitions and capital deployment underscores management’s confidence in sustained demand for electrical infrastructure tied to grid upgrades, electrification, renewables integration, and AI-driven data center projects. We’ll now...
NasdaqGS:TXG
NasdaqGS:TXGLife Sciences

Why 10x Genomics (TXG) Is Up 21.7% After Raising 2026 Outlook Despite Q2 Revenue Drop

In August 2026, 10x Genomics, Inc. reported that second-quarter revenue fell to US$151.04 million from US$172.91 million a year earlier, moving from net income of US$34.54 million to a net loss of US$17.93 million, but simultaneously raised its full-year 2026 revenue guidance to US$610 million–US$630 million from US$600 million–US$625 million. This combination of weaker recent results and a slightly higher full-year outlook highlights a tension between current operating pressure and...
NYSE:DINO
NYSE:DINOOil and Gas

Is HF Sinclair (DINO) Fully Valued As New Base Oil Deals Lift Its Outlook?

HF Sinclair (DINO) is drawing fresh attention after being highlighted as a value stock and announcing new long-term base oil supply and distribution agreements with SK Enmove and Chevron across North America. See our latest analysis for HF Sinclair. For HF Sinclair, these new base oil agreements arrive alongside strong price momentum, with the share price at $87.93 and a year to date share price return of 87.68% and a 1 year total shareholder return of 103.69%. This suggests that investors...
NYSE:CRC
NYSE:CRCOil and Gas

CRC’s Q2 Earnings, Buybacks and CCS Progress Might Change The Case For Investing In California Resources (CRC)

California Resources Corporation recently reported past second-quarter 2026 results, with revenue of US$1,297 million and net income of US$514 million, while affirming production guidance, completing a large share repurchase program, and declaring a quarterly dividend of US$0.405 per share. Together with advancing California’s first commercial carbon capture and storage project and acquiring Crimson Midstream’s pipeline network, these updates reinforce CRC’s integrated model combining oil...
NYSE:RCL
NYSE:RCLHospitality

Carnival Stock And 2 US Cruise Operators Riding Lower Fuel Costs

Cooling inflation, cheaper gas and a less aggressive Federal Reserve have put fuel sensitive travel and leisure stocks back in the spotlight, just as many consumers rethink how they spend on getaways and experiences. This mix of relief and uncertainty can create pockets of opportunity and risk. This article walks through three U.S. Fuel Sensitive Travel and Leisure Operators from our screener that appear especially exposed to these cross currents right now. The stocks covered below are only a...
NYSE:COF
NYSE:COFConsumer Finance

Will Capital One’s 20-Year Arena Deal and Cardholder Perks Strategy Change Capital One Financial’s (COF) Narrative

Monumental Sports & Entertainment recently announced a 20-year extension of Capital One’s naming rights for the reimagined Capital One Arena in Washington, D.C., tied to a more than US$1.00 billion multi-phase transformation scheduled to be completed before the 2027–28 NBA and NHL seasons. The deal deepens Capital One’s presence in live sports and entertainment, using exclusive arena benefits for cardholders to strengthen brand engagement and everyday card usage. Now we’ll examine how this...
NasdaqGS:AMBA
NasdaqGS:AMBASemiconductor

Ambarella (AMBA) Stock May Be Fully Valued As AI Hopes Build

Ambarella stock has delivered a 20.6% return over the past year, yet the company only passes 1 of 6 valuation checks and the Discounted Cash Flow (DCF) intrinsic value estimate points to a share price that is roughly in line with where the market is currently trading it. For investors, the starting point is a stock that no longer looks obviously cheap, even after a solid run. Ambarella's 20.6% 1 year return suggests the market has already priced in a fair amount of optimism about its future...